drugset / Trial / NCT01341548

Civamide Nasal Solution for Cluster Headache

NCT01341548 ↗

Phase 3 Unknown 180 enrolled Winston Laboratories
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the safety and efficacy of intranasally administered civamide nasal solution in the prevention of cluster headaches during an episodic cluster headache period.

Timeline

Start
2023-11
Primary completion
2025-11
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zucapsaicin Small molecule 20 ug Intranasal